Quantum
Quanome CEO to Back Quantum Strategy with Up to $15 Million in Non-Dilutive Growth Capital
Publication: The Quantum Insider
Author: Mohib Ur Rehman
Source published: 01/10/2026, 16:37:34 UTC
Briefing created: 01/10/2026, 23:58:50 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 01/10/2026, 17:49:25 UTC.
Briefings
Quanome Technologies entered into a revolving loan agreement with CEO Yang Li for up to $15 million in non-dilutive growth capital, approved by the Audit Committee. Advances carry 6% annual interest and are intended for working capital and general corporate purposes. Yang Li confirmed his commitment to the company's quantum strategy, which includes AI systems, molecular discovery, advanced nuclear, and quantum-safe cybersecurity. The transaction was reviewed independently by the Board's Audit Committee, with Li abstaining from the vote.
Key points
- Quanome Technologies entered into a revolving loan agreement with CEO Yang Li for up to $15 million in non-dilutive growth capital.
- The transaction was independently reviewed by the Audit Committee, with Li disclosing his interest and abstaining from the committee's deliberations and vote.
Context and limitations
Evidence covers the loan agreement terms, interest rate, and strategic context as of October 2026. Specifics on the draw period duration, exact draw amounts, and future draw requests remain unspecified. The scope of the loan does not include specific disbursements or repayment schedules beyond the revolving nature.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 01/10/2026, 23:58:50 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeiaed3bxhpdpri673jderfzr4fbst4diob36l2k24ntyayaqekrjeq